GlobeStar Therapeutics Co. (OTCMKTS:GSTC) Short Interest Update

GlobeStar Therapeutics Co. (OTCMKTS:GSTC) was the target of a significant decrease in short interest during the month of February. As of February 15th, there was short interest totalling 3,200 shares, a decrease of 91.0% from the January 31st total of 35,600 shares. Based on an average daily trading volume, of 10,934,400 shares, the short-interest ratio is presently 0.0 days.

GlobeStar Therapeutics Stock Performance

GSTC traded up $0.00 on Friday, hitting $0.00. 24,644 shares of the company were exchanged, compared to its average volume of 4,093,090. GlobeStar Therapeutics has a fifty-two week low of $0.00 and a fifty-two week high of $0.00.

About GlobeStar Therapeutics

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. It offers Amethyst, a compound intended to treat neurodegeneration. The company was formerly known as AngioSoma, Inc and changed its name to GlobeStar Therapeutics Corporation in July 2021.